The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
107874456 10787445 6 F 20150202 20160829 20150212 20160829 EXP DE-ROCHE-1536730 ROCHE 71.00 YR F Y 62.00000 KG 20160829 MD DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
107874456 10787445 1 PS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) UNKNOWN 125085 15 MG/KG SOLUTION FOR INFUSION Q3W
107874456 10787445 2 SS PACLITAXEL. PACLITAXEL 1 Intravenous (not otherwise specified) UNKNOWN 0 300 MG Q3W
107874456 10787445 3 SS CARBOPLATIN. CARBOPLATIN 1 Intravenous (not otherwise specified) AUC UNKNOWN 0 440 MG Q3W
107874456 10787445 4 C FUROSEMID FUROSEMIDE 1 Intravenous (not otherwise specified) 0 20 MG Q3W
107874456 10787445 5 C BISOBETA 2 Oral 0 2.5 MG
107874456 10787445 6 C BISOBETA 2 Unknown 0 5 MG
107874456 10787445 7 C ESOMEPRAZOL ESOMEPRAZOLE 1 Oral 0 40 MG
107874456 10787445 8 C NOVAMINSULFON METAMIZOLE 1 Oral 0 30 GTT TID
107874456 10787445 9 C NOVAMINSULFON METAMIZOLE 1 Unknown 0 500 MG
107874456 10787445 10 C ONDANSETRON ONDANSETRON 1 Oral 0
107874456 10787445 11 C ZOLPIDEM ZOLPIDEMOLPIDEM TARTRATE 1 Oral 0
107874456 10787445 12 C RANITIDIN RANITIDINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0 50 MG Q3W
107874456 10787445 13 C FENISTIL (GERMANY) 2 Intravenous (not otherwise specified) 0 4 MG Q3W
107874456 10787445 14 C EMEND APREPITANT 1 Oral AS REQUIRED 0 205 MG
107874456 10787445 15 C STILNOX ZOLPIDEM TARTRATE 1 0
107874456 10787445 16 C TAVOR (LORAZEPAM) LORAZEPAM 1 Unknown 0 1 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
107874456 10787445 1 Bronchial carcinoma
107874456 10787445 2 Bronchial carcinoma
107874456 10787445 3 Bronchial carcinoma
107874456 10787445 4 Prophylaxis
107874456 10787445 5 Hypertension
107874456 10787445 7 Prophylaxis
107874456 10787445 8 Pain
107874456 10787445 10 Prophylaxis of nausea and vomiting
107874456 10787445 11 Sedation
107874456 10787445 12 Prophylaxis
107874456 10787445 13 Prophylaxis
107874456 10787445 14 Prophylaxis

Outcome of event

Event ID CASEID OUTC COD
107874456 10787445 OT
107874456 10787445 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
107874456 10787445 Hypertension
107874456 10787445 Rectal polyp

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
107874456 10787445 1 20150122 20150213 0
107874456 10787445 2 20150122 20150213 0
107874456 10787445 3 20150122 20150213 0
107874456 10787445 4 20150122 20150213 0
107874456 10787445 7 20150121 0
107874456 10787445 8 20141229 0
107874456 10787445 10 20150121 20150213 0
107874456 10787445 11 20150121 0
107874456 10787445 12 20150122 20150213 0
107874456 10787445 13 20150122 20150213 0
107874456 10787445 14 20150122 20150213 0